ReviewMolecular biology reports2025
Exploring the frontier of non-coding RNAs: biogenesis, functional diversity, and disease associations of circRNAs and tinyRNAs.
Review in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The role of epigenetic alterations in canine mammary cancer.The Journal of reproduction and development · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Non-coding RNAs (ncRNAs) represent a pivotal frontier in molecular biology, expanding our understanding of genetic regulation beyond the classical central dogma. Among these, circular RNAs (circRNAs) and tiny RNAs (tyRNAs) have emerged as critical regulators with diverse roles in gene expression, cellular homeostasis, and disease pathogenesis. CircRNAs, characterized by their covalently closed structures, exhibit remarkable stability and functional versatility, including acting as microRNA sponges, transcriptional regulators, and protein scaffolds. Tiny RNAs, a newly recognized class of ncRNAs, are implicated in post-transcriptional regulation through interactions with Argonaute proteins, influencing pathways from viral defense to neurodegenerative diseases. This review synthesizes recent advancements in the biogenesis, molecular mechanisms, and clinical significance of circRNAs and tyRNAs, highlighting their potential as biomarkers and therapeutic targets in cancer, metabolic disorders, and neurological conditions. By exploring their unique regulatory landscapes, this work aims to inspire further research into the ncRNA universe and its implications for human health.
Indexed as
Identifiers
40960700What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.